Evidence map›Paper›PMID 35196197›Full record

ArticleBioengineered2022

Circular RNA-UBE2D2 accelerates the proliferation and metastasis of non-small cell lung cancer cells via modulating microRNA-376a-3p/Eukaryotic Translation Initiation Factor 4γ2 axis.

JiChun Tong, JiaWei Lu, XiaoLiang Mao, Zheng Zhu, YeMin Wang, Ming Lou, Ke Zhang

Open access · goldAbstract read
In one paragraph

Article in Bioengineered, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.0field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Hsa_circ_0102899 promotes epithelial-mesenchymal transition in non-small cell lung cancer.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2023
    Article
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

JiChun TongDepartment of Cardiothoracic Surgery, Changzhou Second People's Hospital, Changzhou City, Jiangsu Province, China.
JiaWei LuDepartment of Cardiothoracic Surgery, Changzhou Second People's Hospital, Changzhou City, Jiangsu Province, China.
XiaoLiang MaoDepartment of Cardiothoracic Surgery, Changzhou Second People's Hospital, Changzhou City, Jiangsu Province, China.
Zheng ZhuDepartment of Cardiothoracic Surgery, Changzhou Second People's Hospital, Changzhou City, Jiangsu Province, China.
YeMin WangDepartment of Cardiothoracic Surgery, Changzhou Second People's Hospital, Changzhou City, Jiangsu Province, China.
Ming LouDepartment of Cardiothoracic Surgery, Changzhou Second People's Hospital, Changzhou City, Jiangsu Province, China.
Ke ZhangDepartment of Cardiothoracic Surgery, Changzhou Second People's Hospital, Changzhou City, Jiangsu Province, China.
Taizhou Second People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Non-small cell lung cancer (NSCLC) ranks first in the morbidity and mortality of malignant tumors in China. As reported, circular RNAs (circRNAs) are emerged in the progress of NSCLC. The study was to figure out the potential mechanism of circ-UBE2D2 in the progression of NSCLC. First, plasmid vectors intervening circ-UBE2D2, microRNA (miR)-376a-3p or Eukaryotic Translation Initiation Factor 4γ2 (EIF4G2) expression were transfected into NSCLC cells, and the expression of circ-UBE2D2, miR-376a-3p and EIF4G2 was detected by reverse transcription quantitative polymerase chain reaction or Western blot. Then, cell proliferation was detected by Cell counting kit-8 assay and plate cloning. Cell apoptosis was tested by flow cytometry. Plate scratches and Transwell were used to detect cell migration and invasion. Finally, the binding sites of circRNA UBE2D2, EIF4G2 and miR-376a-3p were verified by bioinformatics website starBase analysis and dual luciferase reporter gene assay. The results manifested the up-regulation of circ-UBE2D2 expression in NSCLC tissues and cells. Circ-UBE2D2 promoted the proliferation, migration and invasion, but repressed apoptosis of NSCLC cells. Interestingly, circ-UBE2D2 directly targeted miR-376a-3p and up-regulated miR-376a-3p restrained proliferation, migration and invasion, but accelerated apoptosis of NSCLC cells. More importantly, EIF4G2 was the target of miR-376a-3p, and overexpression of EIF4G2 reversed the effects of circ-UBE2D2 downregulation on proliferation, migration, invasion and apoptosis of NSCLC cells. These results suggest that circ-UBE2D2 promotes the proliferation, migration and invasion but restrains apoptosis of lung cancer cells by regulating miR-376a-3p/EIF4G2 axis.

Indexed as

Carcinoma, Non-Small-Cell LungEukaryotic Initiation Factor-4GLung NeoplasmsMicroRNAsRNA, CircularCell MovementCell ProliferationHumansUbiquitin-Conjugating EnzymesEIF4G2 protein, humanEukaryotic Initiation Factor-4GMicroRNAsMIRN376A1 microRNA, humanRNA, CircularUBE2D2 protein, humanUbiquitin-Conjugating EnzymesCircular RNA-UBE2D2Eukaryotic Translation Initiation Factor 4γ2non-small cell lung cancerproliferation

Identifiers

PMID35196197
PMCPMC8974110
OpenAlexW4213421081

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.